Phase I study of TD-0714

Trial Profile

Phase I study of TD-0714

Phase of Trial: Phase I

Latest Information Update: 14 Nov 2016

At a glance

  • Drugs TD 0714 (Primary)
  • Indications Cardiovascular disorders; Kidney disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Nov 2016 New trial record
    • 25 Oct 2016 According to Theravance Biopharma media release, the company expects to progress the IV formulation of TD-0714 into a Phase 1 study in the first half of 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top